ANDA 040797

INVAGEN PHARMS

FDA Drug Application

Application #040797

Application Sponsors

ANDA 040797

INVAGEN PHARMS

Marketing Status

• Prescription: 001
• Prescription: 002

Application Products

001	TABLET;ORAL	200MG	0	MEPROBAMATE	MEPROBAMATE
002	TABLET;ORAL	400MG	0	MEPROBAMATE	MEPROBAMATE

FDA Submissions

ORIG

1

AP

2008-02-27

TE Codes

001	Prescription	AA
002	Prescription	AA

CDER Filings

INVAGEN PHARMS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40797
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEPROBAMATE","activeIngredients":"MEPROBAMATE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEPROBAMATE","activeIngredients":"MEPROBAMATE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MEPROBAMATE","submission":"MEPROBAMATE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"MEPROBAMATE","submission":"MEPROBAMATE","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)